Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Tesla
TSLA
|
+$875M |
| 2 |
Advanced Micro Devices
AMD
|
+$777M |
| 3 |
Home Depot
HD
|
+$564M |
| 4 |
Meta Platforms (Facebook)
META
|
+$505M |
| 5 |
Merck
MRK
|
+$403M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$445M |
| 3 |
Chevron
CVX
|
+$395M |
| 4 |
Micron Technology
MU
|
+$379M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| 1 | Healthcare | 18.68% |
| 2 | Technology | 14.97% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Consumer Staples | 10.73% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Inhibikase Therapeutics
IKT
$116M
| $279K | ﹤0.01% |
31,412
-2,121
| -6% | -$18.8K |
|
|
TUYA
3502
Tuya Inc
TUYA
$1.57B
| $279K | ﹤0.01% |
+94,300
| New | +$279K |
|
|
AMOV
3503
DELISTED
America Movil SAB de CV
AMOV
| $278K | ﹤0.01% |
13,253
| – | – |
|
3504
Forte Biosciences
FBRX
$131M
| $277K | ﹤0.01% |
+7,576
| New | +$277K |
|
3505
Napco Security Technologies
NSSC
$1.5B
| $277K | ﹤0.01% |
13,500
-28,900
| -68% | -$593K |
|
3506
Prelude Therapeutics
PRLD
$64M
| $277K | ﹤0.01% |
40,100
-87,100
| -68% | -$602K |
|
3507
Presidio Property Trust
SQFT
$7.88M
| $277K | ﹤0.01% |
7,455
-772
| -9% | -$28.7K |
|
|
AVEO
3508
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $277K | ﹤0.01% |
+49,600
| New | +$277K |
|
3509
Carisma Therapeutics
CARM
$15.6M
| $276K | ﹤0.01% |
+22,872
| New | +$276K |
|
3510
Key Tronic
KTCC
$38.9M
| $276K | ﹤0.01% |
48,900
-17,875
| -27% | -$101K |
|
3511
Vanguard Small-Cap Growth ETF
VBK
$20.5B
| $273K | ﹤0.01% |
1,100
-1,535
| -58% | -$381K |
|
3512
Exicure
XCUR
$24.5M
| $273K | ﹤0.01% |
9,130
-12,531
| -58% | -$375K |
|
3513
RPAR Risk Parity ETF
RPAR
$542M
| $272K | ﹤0.01% |
11,477
-2,223
| -16% | -$52.7K |
|
3514
Cytosorbents Corp
CTSO
$58.9M
| $271K | ﹤0.01% |
+84,900
| New | +$271K |
|
3515
Lyell Immunopharma
LYEL
$246M
| $270K | ﹤0.01% |
+2,675
| New | +$270K |
|
|
PATI
3516
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
| $270K | ﹤0.01% |
33,808
-4,801
| -12% | -$38.3K |
|
|
BIOC
3517
DELISTED
Biocept, Inc.
BIOC
| $270K | ﹤0.01% |
3,880
+827
| +27% | +$57.5K |
|
3518
Stereotaxis
STXS
$260M
| $269K | ﹤0.01% |
+72,100
| New | +$269K |
|
|
KNTE
3519
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $269K | ﹤0.01% |
+23,900
| New | +$269K |
|
3520
Blackstone Secured Lending
BXSL
$6.58B
| $268K | ﹤0.01% |
+9,600
| New | +$268K |
|
|
WINT
3521
DELISTED
Windtree Therapeutics
WINT
| $267K | ﹤0.01% |
5
| – | – |
|
3522
Avalo Therapeutics
AVTX
$140M
| $266K | ﹤0.01% |
127
+113
| +807% | +$237K |
|
3523
Allbirds
BIRD
$49.9M
| $266K | ﹤0.01% |
+2,211
| New | +$266K |
|
3524
HighPeak Energy
HPK
$899M
| $266K | ﹤0.01% |
+12,000
| New | +$266K |
|
3525
Ovid Therapeutics
OVID
$89.6M
| $266K | ﹤0.01% |
84,800
+26,200
| +45% | +$82.2K |
|